Skip to main content
Log in

Tannins, xenobiotic metabolism and cancer chemoprevention in experimental animals

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Tannins are plant polyphenolic compounds that are contained in large quantities in food and beverages (tea, red wine, nuts,etc.) consumed by humans daily. It has been shown that various tannins exert broad cancer chemoprotective activity in a number of animal models. This review summarizes the recent literature regarding both the mechanisms involved, and the specific organ cancer models used in laboratory animals. An increasing body of evidence demonstrates that tannins act as both anti-initiating and antipromoting agents. In view of the fact that tannins may be of valid medicinal efficacy in human clinical trials, the present review attempts to integrate results from animal studies, and considers their possible application in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Samuelson G. (1992): Drugs of Natural Origin — A textbook of Pharmacognosy, Stockholm: Swedish Pharmaceutical Press.

    Google Scholar 

  2. Machieux J., Fleuriet A., Billot J. (1990): Fruit Phenolics. Boca Raton, FL: CRC Press.

    Google Scholar 

  3. Boukharta M., Jalabert G., Castonquay A. (1992): Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr. Cancer, 18: 181–189.

    Article  PubMed  CAS  Google Scholar 

  4. Mandal S., Stoner G.D. (1990): Inhibition of N-nitroso-benzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis, 11: 55–61.

    Article  PubMed  CAS  Google Scholar 

  5. Wilson T., Lewis M.J., Cha K.L., Gold B. (1992): The effect of ellagic acid on xenobiotic metabolism by cytochrome P450IIE1 and nitrosodimethylamine mutagenicity. Cancer Lett., 61: 129–134.

    Article  PubMed  CAS  Google Scholar 

  6. Singletary K., Liao C.H. (1989): Ellagic acid effects on the carcinogenicity, DNA binding and metabolism of 7,12-dimethylbenz[a]anthracene (DMBA). In Vivo, 3: 173–175.

    PubMed  CAS  Google Scholar 

  7. Chang R.L., Huang M.T., Wood A.W.et al. (1985): Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (±) 7′,8′-dihydroxyl-9a, 10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. Carcinogenesis, 6: 1127–1133.

    Article  PubMed  CAS  Google Scholar 

  8. Leska P. (1983): Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. Carcinogenesis, 4: 1651–1653.

    Article  Google Scholar 

  9. Ip C., Ganther H.E. (1991): Combination of blocking agent and suppressing agent in cancer prevention. Carcinogenesis, 12: 365–367.

    Article  PubMed  CAS  Google Scholar 

  10. Wattenberg L.W. (1985): Chemoprevention of cancer. Cancer Res., 45: 1–8.

    Article  PubMed  CAS  Google Scholar 

  11. Gali H.U., Percellet E.M., Klish D.S., Johnson J.M., Percellet J.P. (1992): Antitumor-promoting activities of hydrolyzable tannins in mouse skin. Carcinogenesis, 13: 715–718.

    Article  PubMed  CAS  Google Scholar 

  12. Akagi K., Hirose M., Hoshiya T., Mizoguchi Y., Ito N., Shirai T. (1995): Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett., 94: 113–121.

    Article  PubMed  CAS  Google Scholar 

  13. Hartig U., Hendricks J.D., Stoner G.D., Bailey G.S. (1996): Organ specific, protocol dependent modulation of 7,12-dimethylbenz[a]anthracene carcinogenesis in rainbow trout (Oncorhynchus mykiss) by dietary ellagic acid. Carcinogenesis, 17: 2403–2409.

    Article  Google Scholar 

  14. Dixit R., Gold B. (1986): Inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA methylation by ellagic acid. Proc. Natl. Acad. Sci. USA, 83: 8039–8043.

    Article  PubMed  CAS  Google Scholar 

  15. Wood A.W., Huang M.T., Chang R.L.,et al. (1982): Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid. Proc. Natl. Acad. Sci. USA, 79: 5513–5517.

    Article  PubMed  CAS  Google Scholar 

  16. Das M., Bickers D.R., Mukhtar H. (1985): Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of its anticarcinogenic action. Carcinogenesis, 6: 1409–1413.

    Article  PubMed  CAS  Google Scholar 

  17. Barch D.H. Fox C.C. (1989): Dietary ellagic acid reduces the esophageal microsomal metabolism of methylbenzylnitrosamine. Cancer Lett., 44: 39–44.

    Article  PubMed  CAS  Google Scholar 

  18. Mukhtar H., Del Tito Jr B.J., Marcelo C.L., Das M., Bickers D.R. (1984): Ellagic acid: a potent naturally occurring inhibitor of benzo[a]pyrene metabolism and its subsequent glucuronidation, sulfation and covalent binding to DNA in cultural BALB/C mouse keratinocyte. Carcinogenesis, 2: 1565–1571.

    Article  Google Scholar 

  19. Mukhtar H., Mukul D., Del Tito Jr B.J., Bickers D.R. (1984): Protection against 3-methylcholanthrene-induced skin tumorigenesis in BALB/C mice by ellagic acid. Biochem. Biophys. Res. Commun., 119: 751–757.

    Article  PubMed  CAS  Google Scholar 

  20. Aryton A.D., Lewis D.F.V., Walker R., Ioannides C. (1992): Antimutagenicity of ellagic acid towards the food mutagen IQ: investitation into possible mechanisms of action. Food Chem. Toxicol., 30: 289–295.

    Article  Google Scholar 

  21. Majid S.M., Khanduja K.L., Gandhi R.K., Kapur S., Sharma R.R. (1991): Influence of ellagic acid on antioxidant defense system and lipid peroxidation in mice. Biochem. Pharmacol., 42: 1441–1445.

    Article  PubMed  CAS  Google Scholar 

  22. Ahn D., Putt D., Kresty L., Stoner G.D., Fromm D., Hollenberg P.F. (1996): The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis, 17: 821–828.

    Article  PubMed  CAS  Google Scholar 

  23. Barch D.H., Rundhaugen L.M. (1994): Ellagic acid induces NAD(P)H: quinone reductase through activation of the antioxidant regulatory element of the rat NAD(P)H: quinone reductase gene. Carcinogenesis, 15: 2065–2068.

    Article  PubMed  CAS  Google Scholar 

  24. Barch D.H., Fox C.C. (1988): Selective inhibition of methylbenzylnitrosamine-induced formation of esophageal O6-methylguanine by dietary ellagic acid in rats. Cancer Res., 48: 7088–7092.

    PubMed  CAS  Google Scholar 

  25. Barch D.H., Rubdhaugen L.M., Stoner G.D., Sokalingum Pillay N., Rosche W.A. (1996): Structure-function relationships of the dietary anticarcinogen ellagic acid. Carcinogenesis, 17: 265–269.

    Article  PubMed  CAS  Google Scholar 

  26. Barch D.H., Farell L.C., Fox C.C., Rosche W.A. (1989): Inhibition of methylnitrosourea-induced formation of O-6-methylguanine by gallic acid. Proc. Am. Assoc. Cancer Res., 30: 171.

    Google Scholar 

  27. Siglin J.C., Barch D.H., Stoner G.D. (1995): Effects of dietary phenethylisothiocyanate, ellagic acid, sulindac, and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Carcinogenesis, 16: 1101–1106.

    Article  PubMed  CAS  Google Scholar 

  28. Dong Z., Ma W., Huang C., Yang C.S. (1997): Inhibition of tumor promoter-induced AP-1 activation and cell transformation by tea polyphenols, (−)-epigallocatechin gallate and theaflavins. Cancer Res., 57: 4414–4419.

    PubMed  CAS  Google Scholar 

  29. Savolainen H. (1992): Tannin content of tea and coffee. J. Appl. Toxicol., 12: 191–192.

    Article  PubMed  CAS  Google Scholar 

  30. Hirose M., Hoshiya T., Akagi K., Futakuchi M., Ito N. (1994): Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[alpha]anthracene. Cancer Lett., 83: 149–156.

    Article  PubMed  CAS  Google Scholar 

  31. Uchida S., Ozaki M., Suzuki K., Shikita M. (1992): Radioprotective effects of (−)-epigallochatechin 3-O-gallate in mice. Life Sci., 50: 147–152.

    Article  PubMed  CAS  Google Scholar 

  32. Hirose M., Ozaki K., Takaba K., Fukushima S., Shirai T., Ito N. (1991): Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid andn-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model. Carcinogenesis, 12: 1917–1921.

    Article  PubMed  CAS  Google Scholar 

  33. Vance R.E., Teel R.W. (1989): Effect of tannic acid on rat liver S9 mediated mutagenesis, metabolism and DNA binding of benzo[a]pyrene. Cancer Lett., 47: 37–44.

    Article  PubMed  CAS  Google Scholar 

  34. Chen G., Perchellet E.M., Gao X.M. et al. (1995): Ability ofm-chloroperoxybenzoic acid to induce the ornithine decarboxylase marker of skin tumor promotion and inhibition of this response by gallotannins, oligomeric proanthocyanidins, and their monomeric units in mouse epidermisin vivo. Anticancer Res., 15: 1183–1189.

    PubMed  CAS  Google Scholar 

  35. Onodera H., Kitaura K., Mitsumori K.et al., (1994): Study on the carcinogenicity of tannic acid in F344 rats. Food Chem. Toxicol., 32: 1101–1106.

    Article  PubMed  CAS  Google Scholar 

  36. Nepka Ch., Antonoglou O., Lazopoulos C., Delkopoulou E., Sivridis E., Kouretas D. (1997): Prophylacticper os tannin administration in hepatoma bearing C3H mice. 3rd Xenobiotic Metabolism and Toxicity workshop of Balkan countries, Varna, Bulgaria, p. 100.

  37. Nepka Ch., Sivridis E., Antonoglou O.et al. (1999): Chemopreventive activity of very low dose dietary tannic acid administration in hepatoma bearing C3H male mice. Cancer Lett.,. In press

  38. Stevenson D., McClain R., Popp J., Slaga T., Ward J., Pitot H. (1990): In: Mouse Liver Carcinogenesis. Progress in clinical and biological Research, Vol 331. New York: Wiley-Liss.

    Google Scholar 

  39. Nishida H., Omori M., Fukutomi Y.et al. (1994): Inhibitory effects of EGCG on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma derived PLC/PRF/5 cells. Jpn. J. Cancer Res., 85: 221–225.

    PubMed  CAS  Google Scholar 

  40. Ramanathan R., Tan C.H., Das N.P. (1992): Cytotoxic effect of plant polyphenols and fat-soluble vitamins on malignant human cultured cells. Cancer Lett., 15: 217–224.

    Article  Google Scholar 

  41. Sakagami H., Kuribayashi N., Iida M.et al. (1995): Induction of DNA fragmentation by tannin- and lignin-related substances. Anticancer Res., 15: 2121–2128.

    PubMed  CAS  Google Scholar 

  42. Yang C., Wang Z.Y. (1993): Tea and cancer. J. Natl. Cancer Inst., 85: 1038–1049.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nepka, C., Asprodini, E. & Kouretas, D. Tannins, xenobiotic metabolism and cancer chemoprevention in experimental animals. Eur. J. Drug Metab. Pharmacokinet. 24, 183–189 (1999). https://doi.org/10.1007/BF03190367

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190367

Keywords

Navigation